Literature DB >> 18955734

Novel promoter I.8 and promoter usage in the CYP19 (aromatase) gene.

Masashi Demura1, Scott Reierstad, Joy E Innes, Serdar E Bulun.   

Abstract

To date, 10 promoters were reported to regulate the expression of the human aromatase (CYP19) gene, giving rise to transcripts with an identical coding region but tissue-specific first exons comprising unique 5'-untranslated regions. We describe the identification and characterization of a new CYP19 exon I, designated exon I.8, in a 5'-rapid amplification of complementary DNA ends-generated library of human THP-1 monocytic cells. A construct containing exon I.8 and its 5'-flanking sequence was sufficient to drive transcription in THP-1 cells. This novel promoter was located approximately 2-kb upstream of promoter I.4 and approximately 75-kb upstream of the common splice junction. We detected several I.8-containing splice variants, 2 of which also contained a sequence from exon I.4. Analysis of human tissues revealed a unique pattern of promoter I.8 usage. The placenta contained the highest level of I.8-specific transcripts. This work underscores the complexity of the mechanisms that regulate normal and pathologic aromatase expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18955734     DOI: 10.1177/1933719108322441

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  9 in total

1.  Genomic basis of aromatase excess syndrome: recombination- and replication-mediated rearrangements leading to CYP19A1 overexpression.

Authors:  Maki Fukami; Takayoshi Tsuchiya; Heike Vollbach; Kristy A Brown; Shuji Abe; Shigeyuki Ohtsu; Martin Wabitsch; Henry Burger; Evan R Simpson; Akihiro Umezawa; Daizou Shihara; Kazuhiko Nakabayashi; Serdar E Bulun; Makio Shozu; Tsutomu Ogata
Journal:  J Clin Endocrinol Metab       Date:  2013-09-24       Impact factor: 5.958

2.  A doxycycline-inducible, tissue-specific aromatase-expressing transgenic mouse.

Authors:  Jenny D Y Chow; John T Price; Margaret M Bills; Evan R Simpson; Wah Chin Boon
Journal:  Transgenic Res       Date:  2011-05-26       Impact factor: 2.788

Review 3.  Brain sex matters: estrogen in cognition and Alzheimer's disease.

Authors:  Rena Li; Jie Cui; Yong Shen
Journal:  Mol Cell Endocrinol       Date:  2014-01-11       Impact factor: 4.102

4.  Changes in aromatase (CYP19) gene promoter usage in non-small cell lung cancer.

Authors:  Masashi Demura; Yoshiki Demura; Shingo Ameshima; Takeshi Ishizaki; Masato Sasaki; Isamu Miyamori; Masakazu Yamagishi; Yoshiyu Takeda; Serdar E Bulun
Journal:  Lung Cancer       Date:  2011-02-12       Impact factor: 5.705

5.  CYP19A1 Promoters Activity in Human Granulosa Cells: A Comparison between PCOS and Normal Subjects.

Authors:  Zohreh Hashemain; Amir Amiri-Yekta; Mona Khosravifar; Faezeh Alvandian; Maryam Shahhosseini; Saman Hosseinkhani; Parvaneh Afsharian
Journal:  Cell J       Date:  2022-04-27       Impact factor: 3.128

Review 6.  Recent experimental and clinical findings in the skeleton associated with loss of estrogen hormone or estrogen receptor activity.

Authors:  Eric P Smith; Bonny Specker; Kenneth S Korach
Journal:  J Steroid Biochem Mol Biol       Date:  2009-11-10       Impact factor: 4.292

7.  High aromatase expression in uterine leiomyoma tissues of African-American women.

Authors:  Hiroshi Ishikawa; Scott Reierstad; Masashi Demura; Alfred W Rademaker; Tadayuki Kasai; Masaki Inoue; Hirokazu Usui; Makio Shozu; Serdar E Bulun
Journal:  J Clin Endocrinol Metab       Date:  2009-02-24       Impact factor: 5.958

8.  DNA methylation within the I.4 promoter region correlates with CYPl19A1 gene expression in human ex vivo mature omental and subcutaneous adipocytes.

Authors:  Joshua R Lewis; Tegan J McNab; Lawrence J Liew; Jeremy Tan; Phillip Hudson; Jenny Z Wang; Richard L Prince
Journal:  BMC Med Genet       Date:  2013-08-30       Impact factor: 2.103

9.  Molecular bases and phenotypic determinants of aromatase excess syndrome.

Authors:  Maki Fukami; Makio Shozu; Tsutomu Ogata
Journal:  Int J Endocrinol       Date:  2012-01-26       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.